Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-24 Sale | 2023-01-26 5:17 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 85,317 | $6.0002 | $511,923 | 971,665 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 4:49 pm | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 100,000 | $6 | $600,000 | 479,565 (Direct) | View |
| 2022-12-29 Sale | 2023-01-03 7:47 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 115,583 | $6.0102 | $694,672 | 3,171,627 (Direct) | View |
| 2022-12-29 Sale | 2023-01-03 6:36 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 54,042 | $6.0058 | $324,564 | 1,493,032 (Direct) | View |
| 2022-11-09 Sale | 2022-11-14 4:42 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 242,300 | $6.004 | $1,454,760 | 1,558,073 (Direct) | View |
| 2022-11-08 Sale | 2022-11-10 4:54 pm | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 91,500 | $5.5849 | $511,019 | 63,000 (Direct) | View |
| 2022-10-04 Sale | 2022-10-06 4:20 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 2,109 | $6.2562 | $13,194 | 991,005 (Direct) | View |
| 2022-09-29 Sale | 2022-10-03 6:26 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 141,041 | $6.0466 | $852,825 | 1,603,063 (Direct) | View |
| 2022-09-16 Sale | 2022-09-20 4:59 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 22,592 | $6.02 | $136,004 | 484,321 (Direct) | View |
| 2022-09-12 Sale | 2022-09-14 4:35 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 242,300 | $6.43 | $1,557,989 | 941,115 (Direct) | View |
| 2022-08-16 Purchase | 2022-08-16 4:07 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 5,000 | $5.5 | $27,500 | 27,861 (Direct) | View |
| 2022-08-09 Sale | 2022-08-11 5:52 pm | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner | 8,500,000 | $6.12 | $52,020,000 | 2,665,438 (Indirect Direct) | View |
| 2022-07-07 Sale | 2022-07-11 4:51 pm | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 20,121 | $6.5104 | $130,995 | 0 (Direct) | View |
| 2022-07-05 Sale | 2022-07-07 5:02 pm | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 91,500 | $6.0772 | $556,067 | 48,621 (Direct) | View |
| 2022-07-01 Sale | 2022-07-06 5:19 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 72,223 | $6.0278 | $435,343 | 3,552,969 (Direct) | View |
| 2022-06-17 Sale | 2022-06-17 4:57 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 60,000 | $6.2084 | $372,505 | 497,397 (Direct) | View |
| 2022-06-14 Sale | 2022-06-16 4:19 pm | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $5.5 | $55,000 | 497,397 (Direct) | View |
| 2022-06-01 Sale | 2022-06-03 6:16 pm | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 72,223 | $6.0025 | $433,520 | 3,763,455 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-05 Option Award | 2023-04-07 6:25 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-04-05 Option Award | 2023-04-07 6:22 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-04-05 Option Award | 2023-04-07 6:20 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | Parks Diane L. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-04-05 Option Award | 2023-04-07 6:17 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-04-05 Option Award | 2023-04-07 6:17 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-04-05 Option Award | 2023-04-07 6:16 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | PERRY MATTHEW D Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2023-04-05 Option Award | 2023-04-07 5:00 pm | N/A 2033-04-05 | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner | 80,000 | $0 | 9,329,807 (Indirect) | View |
| 2023-03-14 Option Award | 2023-03-16 5:52 pm | N/A 2033-03-14 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 900,000 | $0 | 900,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 5:52 pm | N/A 2033-03-14 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 5:52 pm | N/A 2033-03-14 | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-12-16 Ownership | 2023-02-14 6:19 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 43,785 | $0 | 48,639 (Direct) | View |
| 2023-01-24 Exercise | 2023-01-26 5:17 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 85,317 | $0 | 971,665 (Direct) | View |
| 2023-01-24 Exercise | 2023-01-26 5:17 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 85,317 | $0.8411 | 971,665 (Direct) | View |
| 2023-01-24 Exercise | 2023-01-26 4:49 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 100,000 | $0 | 479,565 (Direct) | View |
| 2023-01-24 Exercise | 2023-01-26 4:49 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 100,000 | $0.9489 | 479,565 (Direct) | View |
| 2019-02-19 Option Award | 2023-01-26 4:49 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | Fong James K EVP & Chief Commercial Officer | 288,000 | $0 | 479,565 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 7:47 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 115,583 | $0 | 3,171,627 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 7:47 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 1,579 | $5.1085 | 3,171,627 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 7:47 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 115,583 | $0.8411 | 3,171,627 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 6:36 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 54,042 | $0 | 1,493,032 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 6:36 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 214 | $5.1085 | 1,493,032 (Direct) | View |
| 2022-12-29 Exercise | 2023-01-03 6:36 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 54,042 | $0.9489 | 1,493,032 (Direct) | View |
| 2022-11-09 Exercise | 2022-11-14 4:42 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 242,300 | $0 | 1,558,073 (Direct) | View |
| 2022-11-09 Exercise | 2022-11-14 4:42 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 242,300 | $0.8411 | 1,558,073 (Direct) | View |
| 2022-11-08 Exercise | 2022-11-10 4:54 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 91,500 | $0 | 63,000 (Direct) | View |
| 2022-11-08 Exercise | 2022-11-10 4:54 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 63,000 | $1 | 63,000 (Direct) | View |
| 2022-11-08 Exercise | 2022-11-10 4:54 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 28,500 | $0.8411 | 63,000 (Direct) | View |
| 2022-10-04 Exercise | 2022-10-06 4:20 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 2,109 | $0 | 991,005 (Direct) | View |
| 2022-10-04 Exercise | 2022-10-06 4:20 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 2,109 | $0.9489 | 991,005 (Direct) | View |
| 2022-09-29 Exercise | 2022-10-03 6:26 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 141,041 | $0 | 1,603,063 (Direct) | View |
| 2022-09-29 Exercise | 2022-10-03 6:26 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 141,041 | $0.9489 | 1,603,063 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-20 4:59 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 22,592 | $0 | 484,321 (Direct) | View |
| 2022-06-30 Option Award | 2022-09-20 4:59 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 9,516 | $2.1165 | 484,321 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-20 4:59 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 22,592 | $0.9489 | 484,321 (Direct) | View |
| 2022-09-12 Exercise | 2022-09-14 4:35 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 242,300 | $0 | 941,115 (Direct) | View |
| 2022-09-12 Exercise | 2022-09-14 4:35 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 242,300 | $0.8411 | 941,115 (Direct) | View |
| 2022-08-09 Conversion | 2022-08-11 5:52 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner | 8,395,906 | $0 | 2,665,438 (Direct) | View |
| 2022-07-05 Exercise | 2022-07-07 5:02 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 91,500 | $0 | 48,621 (Direct) | View |
| 2022-07-05 Exercise | 2022-07-07 5:02 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 91,500 | $0.8411 | 48,621 (Direct) | View |
| 2022-07-01 Exercise | 2022-07-06 5:19 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 72,223 | $0 | 3,552,969 (Direct) | View |
| 2022-07-01 Exercise | 2022-07-06 5:19 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 72,223 | $0.8411 | 3,552,969 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-06 5:19 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 6,183 | $2.1165 | 3,552,969 (Direct) | View |
| 2022-06-17 Exercise | 2022-06-17 4:57 pm | N/A 2030-03-11 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 60,000 | $0 | 497,397 (Direct) | View |
| 2022-06-17 Exercise | 2022-06-17 4:57 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $1 | 497,397 (Direct) | View |
| 2022-06-17 Exercise | 2022-06-17 4:57 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 50,000 | $3.3 | 497,397 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 4:19 pm | N/A 2029-02-19 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $0 | 497,397 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 4:19 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 10,000 | $0.9489 | 497,397 (Direct) | View |
| 2022-06-01 Exercise(A) | 2022-06-03 7:15 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 72,223 | $0 | 3,746,777 (Direct) | View |
| 2022-06-01 Exercise | 2022-06-03 6:16 pm | N/A 2029-05-16 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 72,223 | $0 | 3,763,455 (Direct) | View |
| 2022-06-01 Exercise | 2022-06-03 6:16 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 72,223 | $0.8411 | 3,763,455 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 9:03 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Remarks 10% Owner | 80,000 | $0 | 9,379,051 (Indirect) | View |
| 2022-03-09 Option Award | 2022-03-11 7:48 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Tuckson Reed Vaughn Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:46 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | PERRY MATTHEW D Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:46 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Parks Diane L. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:45 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Parkinson David Ross Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:43 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Metzger Michael A Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:42 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Fischer Laurent Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 1,782 | $2.125 | 287,397 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:41 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 280,000 | $0 | 287,397 (Direct) | View |
| 2021-12-31 Option Award | 2022-03-11 7:41 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | KIRSKE DAVID EVP, Chief Financial Officer | 1,817 | $2.108 | 287,397 (Direct) | View |
| 2021-06-30 Option Award | 2022-03-11 7:40 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP, Chief Operating Officer | 3,164 | $2.125 | 323,905 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:40 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP, Chief Operating Officer | 280,000 | $0 | 323,905 (Direct) | View |
| 2021-12-31 Option Award | 2022-03-11 7:40 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | SEELEY BRUCE J. EVP, Chief Operating Officer | 3,241 | $2.108 | 323,905 (Direct) | View |
| 2022-03-09 Option Award | 2022-03-11 7:39 pm | N/A 2032-03-09 | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 1,115,000 | $0 | 1,131,678 (Direct) | View |
| 2021-12-31 Option Award | 2022-03-11 7:39 pm | N/A N/A | CTI BIOPHARMA CORP | CTIC | Craig Adam R President and CEO | 3,178 | $2.108 | 1,131,678 (Direct) | View |